GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Aarti Pharmalabs AARTIPHARM.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

921.40

-0.83%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2026

Revenue

₹18.19bn

FY2020FY2026

Net income

₹1.75bn

FY2020FY2026

Free cash flow

−₹1.86bn

FY2020FY2026

Shareholders' equity

₹21.25bn

FY2020FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020
Revenue₹18.19bn₹21.15bn₹18.16bn₹19.45bn₹11.94bn——
Research and development₹328.5m₹328.3m₹83.7m₹139.6m₹58.2m——
Operating income₹2.98bn₹3.77bn₹2.96bn₹2.80bn−₹769,760−₹45,960−₹187,000
Net income₹1.75bn₹2.72bn₹2.17bn₹1.93bn−₹771,378−₹45,960−₹187,000
Diluted earnings per share19.2530.0523.9221.34-0.01-0.00-0.00

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020
Total assets₹34.82bn₹29.06bn₹25.82bn₹22.44bn₹20.40bn₹2.5m₹2.5m
Cash and short-term investments₹96.2m₹562.1m₹940.3m₹631.1m₹832.7m₹2.5m₹2.5m
Total liabilities₹13.57bn₹9.16bn₹8.25bn₹6.86bn₹6.53bn₹232,711₹186,751
Debt₹7.54bn₹4.13bn₹2.85bn₹2.15bn₹3.41bn₹173,000₹186,751
Shareholders' equity₹21.25bn₹19.90bn₹17.57bn₹15.58bn₹13.86bn₹2.3m₹2.3m
Shares outstanding91m91m91m91m91m45m91m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020
Cash from operations₹2.62bn₹3.32bn₹2.16bn₹2.63bn−₹437.0m—−₹186,751
Capital spending−₹4.48bn−₹4.02bn−₹1.99bn−₹1.20bn−₹1.41bn——
Free cash flow−₹1.86bn−₹704.8m₹175.7m₹1.43bn−₹1.85bn—−₹186,751
Dividends paid−₹362.6m−₹317.2m−₹181.3m−₹181.3m———

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₹5.36bn₹5.83bn₹4.32bn₹4.18bn₹3.86bn₹5.64bn₹5.38bn₹4.58bn
Operating income₹1.03bn₹1.02bn₹736.9m₹499.5m₹724.5m₹1.23bn₹1.06bn₹727.9m
Net income₹761.4m₹611.2m₹479.6m₹279.2m₹495.0m₹883.4m₹739.9m₹546.2m
Diluted earnings per share8.396.745.293.085.469.748.166.02
Cash from operations———₹996.0m————
Capital spending———−₹2.16bn————
Free cash flow———−₹1.17bn————
Total assets—₹34.82bn—₹32.66bn—₹29.06bn—₹27.77bn
Cash and short-term investments₹96.2m₹96.2m₹555.6m₹555.6m₹562.1m₹562.1m₹995.1m₹995.1m
Debt—₹7.02bn—₹6.05bn—₹4.09bn—₹3.74bn
Shareholders' equity₹21.25bn₹21.25bn₹20.46bn₹20.46bn₹19.90bn₹19.90bn₹18.57bn₹18.57bn

Financial ratios

Data as of 15 Sept 2026

FY2026FY2025FY2024FY2023FY2022FY2021
Operating margin16.4%17.8%16.3%14.4%-0.0%—
Net margin9.6%12.9%11.9%9.9%-0.0%—
Return on equity8.2%13.7%12.3%12.4%-0.0%-2.0%
Return on assets5.0%9.4%8.4%8.6%-0.0%-1.8%
Free cash flow yield9.9%10.2%5.8%5.3%1.4%—
Revenue growth-14.0%16.5%-6.7%63.0%——
Earnings growth-35.9%25.6%12.1%-250941.2%1578.4%-75.4%
Current ratio1.49x2.01x1.94x1.94x1.77x11.42x
Debt to equity0.33x0.21x0.15x0.14x0.25x0.16x
Equity ratio61.0%68.5%68.0%69.5%68.0%90.7%
Interest coverage6.36x14.03x17.18x13.28x-475.75x—
R&D as a share of sales1.8%1.6%0.5%0.7%0.5%—
Buybacks as a share of market value-0.1%0.0%-0.0%0.0%-99.5%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-2.2%——
Operating income2.2%——
Net income-3.3%——

Average margins

Over each period

1 year3 years5 years10 years
Operating margin17.2%16.3%——
Net margin11.4%11.1%——

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023
Price to earnings48.525.028.723.6
Price to sales4.73.23.42.4

Dividends and splits

Per share, in the currency the company pays

Paid for 2 years. Last went ex-dividend on 15 Sept 2026.

FY2027FY2026FY2025FY2024
Paid in the year2.004.003.502.00

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.